Access to anti-retroviral drugs, female in Kyrgyzstan
Kyrgyzstan: Access to anti-retroviral drugs, female was 60.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Kyrgyzstan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Kyrgyzstan stood at 60.0%. That is the highest value across all 25 years on record.
The figure is up 3.4% on the previous year and up 140.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Kyrgyzstan peaked at 60.0% in 2024 and was at its lowest, 0.0%, in 2000.
Kyrgyzstan ranks 103rd of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Kyrgyzstan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 1.0% | — |
| 2008 | 2.0% | +100.0% |
| 2009 | 4.0% | +100.0% |
| 2010 | 6.0% | +50.0% |
| 2011 | 9.0% | +50.0% |
| 2012 | 12.0% | +33.3% |
| 2013 | 18.0% | +50.0% |
| 2014 | 25.0% | +38.9% |
| 2015 | 30.0% | +20.0% |
| 2016 | 35.0% | +16.7% |
| 2017 | 41.0% | +17.1% |
| 2018 | 43.0% | +4.9% |
| 2019 | 45.0% | +4.7% |
| 2020 | 48.0% | +6.7% |
| 2021 | 52.0% | +8.3% |
| 2022 | 56.0% | +7.7% |
| 2023 | 58.0% | +3.6% |
| 2024 | 60.0% | +3.4% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 60.0% is below the median for lower middle income countries, which is 80.0%, 75% of the median. (39 countries reporting)
- Kyrgyzstan's 60.0% is below the median for Europe & Central Asia, which is 83.0%, 72% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 4.0% | 10 |
| 2010s | 26.4% | 6.0% | 45.0% | 10 |
| 2020s | 54.8% | 48.0% | 60.0% | 5 |
Countries ranked near Kyrgyzstan
More gender data for Kyrgyzstan
- Child population (UN estimates and projections) 2,300 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5338 % change on previous year (2030)
- Population 5,504 (2030)
- Working-age population (UN estimates and projections) 5,504 (2030)
- Population (UN estimates and projections), annual growth rate 2.06 % change on previous year (2030)
- Age population, age 00, female, interpolated 72,260 (2025)
- Age population, age 00, male, interpolated 76,154 (2025)
- Age population, age 01, female, interpolated 72,405 (2025)
- Age population, age 01, male, interpolated 76,252 (2025)
- Age population, age 02, female, interpolated 72,315 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Kyrgyzstan?
- Access to anti-retroviral drugs, female in Kyrgyzstan was 60.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Kyrgyzstan?
- The highest recorded value was 60.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Kyrgyzstan?
- The lowest recorded value was 0.0% in 2000.
- How does Kyrgyzstan rank for access to anti-retroviral drugs, female?
- Kyrgyzstan ranks 103rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Kyrgyzstan?
- Over the last ten years it is up 140.0%. The long-run trend across the full record is volatile.
- Where does this Kyrgyzstan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.